Navigation Links
DST Systems, Inc. Announces Exchange Transaction Involving 4.125% Series A Convertible Senior Debentures
Date:10/1/2009

KANSAS CITY, Mo., Oct. 1 /PRNewswire-FirstCall/ -- DST Systems, Inc. (NYSE: DST) (the "Company") today announced that the Company has entered into separate privately negotiated exchange agreements under which it will exchange $190.4 million in aggregate principal of the Company's outstanding 4.125% Series A Convertible Senior Debentures due 2023 ("Existing Debentures") for $190.4 million in aggregate principal of new 4.125% Series C Convertible Senior Debentures due 2023 ("New Debentures"). The New Debentures are convertible under certain circumstances by holders into shares of DST common stock per $1,000 original principal amount of debentures at an initial conversion rate of 20.3732 shares (subject to adjustment in certain events). This is equivalent to an initial conversion price of $49.08 per share for the New Debentures.

Shares of the Company's common stock, into which the New Debentures are convertible, have been reserved for issuance by the Company and listed on the New York Stock Exchange. Holders of the New Debentures have the option to require the Company to purchase the notes on August 15, 2014 and certain subsequent dates, and in certain other circumstances, at a price equal to the accreted principal amount of the Series C debentures to be purchased plus any accrued and unpaid interest. The Company has the right to redeem the New Debentures beginning August 15, 2013.

No Solicitation

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The information and comments in this press release may include forward-looking statements respecting DST and its businesses. Such information and comments are based on DST's views as of today, and actual actions or results could differ. There could be a number of factors, risks, uncertainties or contingencies that could affect future actions or results, including but not limited to those set forth in DST's periodic reports (Form 10-K or 10-Q) filed from time to time with the Securities and Exchange Commission. All such factors should be considered in evaluating any forward-looking statements. The Company undertakes no obligation to update any forward-looking statements in this press release to reflect future events.

SOURCE DST Systems, Inc.


'/>"/>
SOURCE DST Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
2. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
3. CAS Medical Systems, Inc. Awarded $2.8 Million Grant by National Institutes of Health
4. Mediware Information Systems, Inc. Receives Notice from the Nasdaq Stock Market
5. FDA Grants Clearance to Langford IC Systems, Inc.
6. Four Rivers Software Systems, Inc. Announces the Promotion of Samantha Rouse to Senior Vice President of Product and Services
7. CAS Medical Systems, Inc. Ranked Among Connecticuts Fastest Growing Technology Companies
8. StatSure Diagnostic Systems, Inc. (OTC Bulletin Board: SSUR) Review Issued By Scimitar Equity Research, Inc.
9. Acclamation Systems, Inc. Renews Partnership with Coalition America to Offer Streamlined Repricing and Adjudication Solution
10. RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US
11. AdCare Health Systems, Inc. Announces 2007 Third Quarter Earnings Release and Conference Call Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi and Dr. Douglas ... not do their research and undergo cosmetic dermatology treatments from unqualified practitioners or worse, ... renaissance and every other month a new treatment or device is launched, promising everlasting ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... Mentz won "Best Surgical Facial Rejuvenation" at the 2016 Anti-Aging & Beauty ... France. , The Aesthetic & Anti-aging Medicine European Congress (AMEC) brings ...
(Date:12/5/2016)... ... December 05, 2016 , ... A newly released study has ... reproducibility and accuracy of placing precordial electrodes with little cognitive effort and a ... 60 years, studies have shown that single electrode misplacement is one of the ...
(Date:12/4/2016)... NY (PRWEB) , ... December 03, 2016 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – hosted its first Swirl: A Wine Tasting Event in New York City, ...
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... 3, 2016 Johnson & Weaver, LLP announces that ... of Zimmer Biomet Holdings, Inc. (NYSE: ZBH ) ... 31, 2016 (the "Class Period"). Zimmer Biomet provides ... orthopaedic reconstructive products, such as knee and hip reconstructive products. ... , , ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)...  Results from the Phase II SUSTAIN study show ... the median annual rate of sickle cell-related pain crises ... p=0.010) in patients with or without hydroxyurea therapy 1 ... featured in the official press briefing at the 58 ... and presented during the Plenary Scientific Session tomorrow (Abstract ...
Breaking Medicine Technology: